📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.02053-2017

PubMed Identifier: 29371384

Publication URI: http://europepmc.org/abstract/MED/29371384

Type: Journal Article/Review

Volume: 51

Parent Publication: The European respiratory journal

Issue: 1

ISSN: 0903-1936